Increase in local reactions after booster dose for 4-year-olds with DPT;Toename van lokale verschijnselen bij 4-jarigen na revaccinatie met DKTP

Nederlands Tijdschrift voor Geneeskunde

Volumn 154, Issue 14, 2010, Pages 639-642

  David, Silke ^a   Vermeer De Bondt, Patricia ^a   Van Der Maas, Nicoline ^a  

^a Rijks Instituut Voor Volksgezondheid en Milieu   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; DIPHTHERIA PERTUSSIS TETANUS VACCINE; TRIAXIS; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; CHILD; DIPHTHERIA; DRUG HYPERSENSITIVITY; HEALTH PROGRAM; HUMAN; IMMUNIZATION; PERTUSSIS; PRESCHOOL CHILD; REVACCINATION; TETANUS;

EID: 77951260860     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Vermeer-de Bondt PE, Dzaferagic A, Phaff TAJ, Wesselo C, Maas NAT van der. Adverse Events Following Immunisation under the National Vaccination Programme of The Netherlands, nr. XI. Bilthoven: RIVM; 2004.
2. Gezondheidsraad. Vaccinatie tegen kinkhoest. 2004/04. Den Haag: Gezondheidsraad; 2004.
3. Decker MD, Edwards KM, Stinhoff MC, Rennels MB, Pichichero ME, Englund JA, Anderson EL, Deloria MA, Reed GF. Comparison of 13 acellular pertussis vaccines: adverse reactions. Pediatrics. 1995;96;557-566
4. Greco D, Salmaso S, Mastrantonio P, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med. 1996;334:345-348 (Pubitemid 26053148)
5. Olin P, Rasmussen F, Gustafsson L, et al. Randomised trial of two-component, three-component and five component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Lancet. 1997;350:1569-1577 (Pubitemid 28036599)
6. David S, Vermeer-de Bondt PE, Maas van der NAT. Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines wit hor without simultaneous pneumococcal vaccine in the Netherlands. Vaccine. 2008;26:5883-5887
7. Maas NAT, David S, Kemmeren JM, Vermeer-de Bondt PE. Veiligheidsbewaking van Rijksvaccinatieprogramma; minder bijwerkingen van DKTP-Hib-combinatievaccin sinds overgang in 2005 naar vaccin met acellulaire kinkhoestcomponent. Ned Tijdschr Geneeskd. 2007;49:2732-2737
8. Pichichero ME, Edwards KM, Anderson EL, Rennels MB, Englund JA, Yerg DE, Blackwelder WC, Jansen DL, Meade BD. Safety and immunogenicity of six acelllar pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children. Pediatrics. 2000;105:11-19
9. Annunziato PW, Rothstein EP, Bernstein HH, Blatter MM, Reisinger KS, Pichichero ME. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 4- through 6-year old children. Archives of pediatrics & adolescent medicine. 1994;148:503-507 (Pubitemid 24153241)
10. Woo EJ, Burwen DR, Gatumu SN, Ball R. Extensive limb swelling after immunization: reports to the Vaccine Adverse Event Reporting System. Clin Infect Dis. 2003;37:351-358 (Pubitemid 36976492)
11. Tam T, Scheifele DW Local adverse reactions following a booster dose of acellular pertussis DT vaccine: lack of effect of loratidine prophylaxis (abstract). In: Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, September 15-18, 1996. Washington, D.C.: American Society for Microbiology, 1996:G104.
12. Casey JR, Pichichero ME. Acellular pertussis vaccine safety and efficacy in children, adolescents and adults. Drugs. 2005;65:1367-1389 (Pubitemid 41043892)
13. Halparin SA, Scheifele D, Mills E, Guasparini R, Humphreys G, Barreto L, et al. Nature, evolution and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine. Vaccine. 2003;21:2298-2306 (Pubitemid 36561321)